# DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)

> **NCT00187187** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 600 (actual)

## Conditions studied

- Ventricular Tachycardia
- Ventricular Fibrillation
- Sudden Cardiac Death
- Congestive Heart Failure

## Interventions

- **DEVICE:** Implantable Defibrillator (ICD)
- **DEVICE:** Implantable Defibrillator (ICD)

## Key facts

- **NCT ID:** NCT00187187
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187187, "DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00187187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*